诺和诺德中国招聘

Novo Nordisk in China
As the leader in the Chinese market, Novo Nordisk has always been committed to changing. Novo Nordisk (China) Pharmaceuticals Co., Ltd. was established in 1994. Over the past two decades, its business has maintained strong growth. Headquartered in Beijing, the company provides products and services across all provinces, municipalities, and regions of China including Hong Kong, Macau and *** of China. By the end of 2017, Novo Nordisk had a total of 4,329 employees in China. Novo Nordisk is a biopharmaceutical company that has established a research and development center in China. The R&D center in Beijing is part of Novo Nordisk's global R&D system, dedicated to collaborating with headquarters on the development of new products and processes. The production plant in Tianjin, China, is part of Novo Nordisk's international strategic production base. The company has invested substantial funds and technical support into the factory, supplying products to both global and Chinese markets. Novo Nordisk's continuous development in China reflects the company's commitment to the Chinese market.